- Home
- XBIO vs YGMZ Comparison
XBIO vs YGMZ Comparison
Compare XBIO & YGMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIO
- YGMZ
- Stock Information
- Founded
- XBIO N/A
- YGMZ 2002
- Country
- XBIO United States
- YGMZ China
- Employees
- XBIO N/A
- YGMZ N/A
- Industry
- XBIO Biotechnology: Pharmaceutical Preparations
- YGMZ Transportation Services
- Sector
- XBIO Health Care
- YGMZ Consumer Discretionary
- Exchange
- XBIO Nasdaq
- YGMZ Nasdaq
- Market Cap
- XBIO 6.3M
- YGMZ 7.0M
- IPO Year
- XBIO N/A
- YGMZ 2020
- Fundamental
- Price
- XBIO $4.24
- YGMZ $0.86
- Analyst Decision
- XBIO Hold
- YGMZ
- Analyst Count
- XBIO 1
- YGMZ 0
- Target Price
- XBIO N/A
- YGMZ N/A
- AVG Volume (30 Days)
- XBIO 11.0K
- YGMZ 124.8K
- Earning Date
- XBIO 11-12-2024
- YGMZ 01-01-0001
- Dividend Yield
- XBIO N/A
- YGMZ N/A
- EPS Growth
- XBIO N/A
- YGMZ N/A
- EPS
- XBIO N/A
- YGMZ N/A
- Revenue
- XBIO $2,523,427.00
- YGMZ $55,805,416.00
- Revenue This Year
- XBIO N/A
- YGMZ N/A
- Revenue Next Year
- XBIO N/A
- YGMZ N/A
- P/E Ratio
- XBIO N/A
- YGMZ N/A
- Revenue Growth
- XBIO 7.15
- YGMZ N/A
- 52 Week Low
- XBIO $2.78
- YGMZ $0.68
- 52 Week High
- XBIO $5.20
- YGMZ $6.24
- Technical
- Relative Strength Index (RSI)
- XBIO 53.05
- YGMZ 44.05
- Support Level
- XBIO $3.93
- YGMZ $0.68
- Resistance Level
- XBIO $4.32
- YGMZ $0.85
- Average True Range (ATR)
- XBIO 0.25
- YGMZ 0.09
- MACD
- XBIO 0.01
- YGMZ -0.01
- Stochastic Oscillator
- XBIO 84.31
- YGMZ 40.23
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.
About YGMZ MingZhu Logistics Holdings Limited
MingZhu Logistics Holdings Ltd is a Holding company. Its business activities include trucking services and car owner services. Its segments are the trucking business, car owner services business, and liquor distribution business. It generates the majority of its revenue from the trucking segment.